What is CBC?
Cannabichromene, or CBC, is a powerful, non-psychoactive cannabinoid, meaning it will not cause a patient to feel “high.” CBC, like THC and CBD, has been shown to encourage the human brain to grow by increasing the viability of developing brain cells in a process known as neurogenesis. CBC plays a significant role in the anti-cancer and anti-tumor capabilities of cannabis.
CBC battles inflammation, as well, but without activating any of the endocannabinoid receptors in the body. For this reason, the healing powers of CBC increase significantly when combined with other cannabinoids, like THC or CBD, which do activate endocannabinoid receptors in the brain and throughout the body.
Effects and Benefits
Research has shown that CBC is effective in the treatment of a variety of symptoms and conditions. Examples of conditions for which CBC is particularly effective in providing symptom relief are listed below:
- Irritable bowel syndrome
- Crohn’s disease
- Chronic post-operative pain
Links to research
Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anesthetized rats through several mechanisms of action.
Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.
Biological activity of cannabichromene, its homologs and isomers.
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
While research has shown cannabis to be effective in providing palliative and therapeutic effects for some patients, always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition and before starting any new treatment utilizing medical cannabis or discontinuing an existing treatment. The content on this site is not intended to be a substitute for professional medical advice, diagnosis or treatment.